No Data
No Data
Express News | Gilead : Jefferies Raises Target Price to $95 From $90
Gilead Sciences Trades in the Green for Seventh Straight Session
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here Is What You Need to Know